SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Strong Long who wrote (1931)5/10/2016 5:15:03 PM
From: mokelumne river   of 2026
 
This is an excerpt from today's Fierce Biotech article entitled, "Big biopharma execs really just want to talk about biotech deals." Note that Brent Saunders is CEO/Chair of Allergan, the outfit that has rights to market Vitaros if the FDA approves it and if Allergan chooses to exercise. It appears from their balance sheet that Allergan could pick up Apricus from the lint in their deep pocket.

"Brent Saunders at Allergan is a dealmaker at heart, and even with $10 billion now being set aside to buy back the company’s stock, he still has a $36 billion windfall coming from Teva ($TEVA). Now that the Pfizer ($PFE) megainversion attempt is history, most analysts expect Saunders is once again working the phones--if indeed he ever stopped--to continue to beef up the pipeline, adding to acquisitions that range from ambitious CNS programs to smaller deals designed to expand Allergan’s proprietary hold on facial remodeling.

Saunders has signaled repeatedly that he’s far less interested in translational research than the late-stage variety. It’s still plenty risky, but the catalysts are bigger and closer. And Saunders has shown no reluctance in putting up sizable upfront payments to get these deals across the finish line."

Mind you, I suspect that Saunders doesn't even know what Vitaros is...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News